Physcion 8‑O‑β‑glucopyranoside extracted from Polygonum cuspidatum exhibits anti‑proliferative and anti‑inflammatory effects on MH7A rheumatoid arthritis‑derived fibroblast‑like synoviocytes through the TGF‑β/MAPK pathway

Geng,Qin; Wei,Qiaofeng; Wang,Shujun; Qi,Huili; Zhu,Qin; Liu,Xia; Shi,Xiaojun; Wen,Shuyun

doi:10.3892/ijmm.2018.3649

Physcion 8‑O‑β‑glucopyranoside extracted from Polygonum cuspidatum exhibits anti‑proliferative and anti‑inflammatory effects on MH7A rheumatoid arthritis‑derived fibroblast‑like synoviocytes through the TGF‑β/MAPK pathway

Authors:
- Qin Geng
- Qiaofeng Wei
- Shujun Wang
- Huili Qi
- Qin Zhu
- Xia Liu
- Xiaojun Shi
- Shuyun Wen
View Affiliations

Affiliations: Department of Rheumatology, Shandong Zibo Central Hospital, Zibo, Shandong 255036, P.R. China, Dezhou People's Hospital, Department of Traditional Chinese Medicine Rheumatology, Dezhou, Shandong 253000, P.R. China
Published online on: April 30, 2018 https://doi.org/10.3892/ijmm.2018.3649
Pages: 745-754
Copyright: © Geng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the anti‑arthritic effect of physcion 8‑O‑β‑glucopyranoside (POGD) and its possible mechanisms. The anti‑proliferative effects of POGD on MH7A cells were detected using a CCK‑8 assay, and the release of pro‑inflammatory cytokines, interleukin (IL)‑1β, IL‑6, IL‑8, IL‑12 and IL‑17A, were determined by ELISA. A type II collagen‑induced arthritis (CIA) rat model was established to evaluate the anti‑arthritic effect of POGD in vivo. The paw volumes, arthritis indices and serum levels of tumor necrosis factor (TNF)‑α, IL‑1β, IL‑6, IL‑8, IL‑17A were determined by ELISA. The mRNA expression levels of matrix metalloproteinase (MMP)‑2, MMP‑3, MMP‑9, vascular endothelial growth factor and cyclooxygenase‑2 were determined by reverse transcription‑quantitative polymerase chain reaction analysis, and the expression levels of transforming growth factor (TGF)‑β1, small mothers against decapentaplegic (Smad)4, Smad7, c‑Jun N‑terminal kinase (JNK), phosphorylated (p‑)JNK, p‑P38, P38, p‑extracellular signal‑regulated kinase (ERK)1/2, ERK1/2, nuclear factor (NF)‑κB p65 in the nucleus (N), cytosolic NF‑κB p65 (C), and inhibitor of NF‑κB (IκB) were determined by western blot analysis. The results indicated that POGD significantly inhibited MH7A cell growth. POGD markedly inhibited paw swelling and the arthritis indices of the CIA rats, and POGD may also inhibit the release of pro‑inflammatory cytokines. Furthermore, POGD downregulated the expression levels of TGF‑β1, Smad4, NF‑κB p65 (N), p38, p‑p38, p‑ERK1/2, JNK, p‑JNK, TGF‑β1, Smad4, p‑JNK, JNK, p‑P38, P38, p‑ERK1/2, ERK1/2 and NF‑κB p65 (N), and upregulated the Smad7, NF‑κB p65 (C) and IκB in TNF‑α induced MH7A cells. In conclusion, the results suggested that POGD is a promising potential anti‑inflammatory drug, and that POGD may decrease the expression of pro‑inflammatory cytokines and mediators via inhibiting the TGF‑β/NF‑κB/mitogen‑activated protein kinase pathways.

View Figures

View References

1	Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, et al: Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 506:376–381. 2014. View Article : Google Scholar : PubMed/NCBI
2	Fry J, Moulds A, Strube G and Gambrill E: Rheumatic diseases. In: The family good health guide. Springer. 157–164. 1982.
3	Collison J: Experimental arthritis: Do you want to treat arthritis? IDO2. Nat Rev Rheumatol. 13:196–197. 2017.PubMed/NCBI
4	Firestein GS and McInnes IB: Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196. 2017. View Article : Google Scholar : PubMed/NCBI
5	Calabrese LH, Calabrese C and Kirchner E: The 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis should include new standards for hepatitis B screening: Comment on the article by Singh et al. Arthritis Care Res. 68:723–724. 2016. View Article : Google Scholar
6	Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, et al: 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68:1–26. 2016. View Article : Google Scholar
7	Mor A, Abramson SB and Pillinger MH: The fibroblast-like synovial cell in rheumatoid arthritis: A key player in inflammation and joint destruction. Clin Immunol. 115:118–128. 2005. View Article : Google Scholar : PubMed/NCBI
8	Peng W, Qin R, Li X and Zhou H: Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: A review. J Ethnopharmacol. 148:729–745. 2013. View Article : Google Scholar : PubMed/NCBI
9	Xie QC and Yang YP: Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest. BMC Complement Altern Med. 14:3772014. View Article : Google Scholar
10	Zhao KS, Jin C, Huang X, Liu J, Yan WS, Huang Q and Kan W: The mechanism of Polydatin in shock treatment. Clin Hemorheol Microcirc. 29:211–217. 2003.
11	Bralley EE, Greenspan P, Hargrove JL, Wicker L and Hartle DK: Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm. 5:12008. View Article : Google Scholar
12	Hsu CY, Chan YP and Chang J: Antioxidant activity of extract from Polygonum cuspidatum. Biol Res. 40:13–21. 2007. View Article : Google Scholar : PubMed/NCBI
13	Kimura Y and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutri. 131:1844–1849. 2001. View Article : Google Scholar
14	Zhang H, Yu CH, Jiang YP, Peng C, He K, Tang JY and Xin HL: Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice. PLoS One. 7:e465742012. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C T method. Methods. 25:402–408. 2001. View Article : Google Scholar
16	Pu J, Fang FF, Li XQ, Shu ZH, Jiang YP, Han T, Peng W and Zheng CJ: Matrine exerts a strong anti-arthritic effect on type II collagen-induced arthritis in rats by inhibiting inflammatory responses. Int J Mol Sci. 17:E14102016. View Article : Google Scholar : PubMed/NCBI
17	Tran CN, Lundy SK and Fox DA: Synovial biology and T cells in rheumatoid arthritis. Pathophysiology. 12:183–189. 2005. View Article : Google Scholar : PubMed/NCBI
18	Ospelt C and Gay S: The role of resident synovial cells in destructive arthritis. Best Prac Res Clin Rheumatol. 22:239–252. 2008. View Article : Google Scholar
19	Zuo J, Xia Y, Li X, Ou-Yang Z and Chen JW: Selective modulation of MAPKs contribute to the anti-proliferative and anti-inflammatory activities of 17-dihydroxy-3,4-dimethoxyxanthone in rheumatoid arthritis-derived fibroblast-like synoviocyte MH7A cells. J Ethnopharmacol. 168:248–254. 2015. View Article : Google Scholar : PubMed/NCBI
20	Myers LK, Rosloniec EF, Cremer MA and Kang AH: Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61:1861–1878. 1997. View Article : Google Scholar : PubMed/NCBI
21	Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V and Bathon JM: Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 55:333–337. 2006. View Article : Google Scholar : PubMed/NCBI
22	Umar S, Hedaya O, Singh AK and Ahmed S: Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Toxicol Appl Pharmacol. 287:299–305. 2015. View Article : Google Scholar : PubMed/NCBI
23	Lianxu C, Hongti J and Changlong Y: NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chon-drocytes. Osteoarthritis Cartilage. 14:367–376. 2006. View Article : Google Scholar
24	Tian J, Chen JW, Gao JS, Li L and Xie X: Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3k inase/Akt pathway. Rheumatol Int. 33:1829–1835. 2013. View Article : Google Scholar : PubMed/NCBI
25	Burrage PS, Mix KS and Brinckerhoff CE: Matrix metalloproteinases: Role in arthritis. Front Biosci. 11:529–543. 2006. View Article : Google Scholar
26	Aggarwal BB, Shishodia S, Sandur SK, Pandey MK and Sethi G: Inflammation and cancer: How hot is the link. Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
27	Hawkey CJ: COX-2 inhibitors. Lancet. 353:307–314. 1999. View Article : Google Scholar : PubMed/NCBI
28	Koch A: Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis. 62(Suppl 2): ii60–ii67. 2003. View Article : Google Scholar : PubMed/NCBI
29	Nagashima M, Yoshino S, Ishiwata T and Asano G: Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol. 22:1624–1630. 1995.PubMed/NCBI
30	Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M and Maini RN: Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 41:1258–1265. 1998. View Article : Google Scholar : PubMed/NCBI
31	Cheon H, YU SJ, Yoo DH, Chae IJ, Song GG and Sohn J: Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol. 127:547–552. 2002. View Article : Google Scholar : PubMed/NCBI
32	Goldring S: Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology. 42(Suppl 2): ii11–ii16. 2003. View Article : Google Scholar : PubMed/NCBI
33	Keyse SM: Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27:253–261. 2008. View Article : Google Scholar : PubMed/NCBI
34	Kaminska B: MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI
35	Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
36	Baker RG, Hayden MS and Ghosh S: NF-κB, inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011. View Article : Google Scholar : PubMed/NCBI
37	Vallabhapurapu S and Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Ann Rev Immunol. 27:693–733. 2009. View Article : Google Scholar
38	Beg AA and Baldwin AS Jr: The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064–2070. 1993. View Article : Google Scholar : PubMed/NCBI
39	Lyss G, Knorre A, Schmidt TJ, Pahl HL and Merfort I: The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem. 273:33508–33516. 1998. View Article : Google Scholar : PubMed/NCBI